A61P 27/08
Mydriatics or cycloplegics
A61P27/08 (Mydriatics or cycloplegics) appears on 92 US grants and 140 published applications in this corpus.
Search patents in A61P- Granted patents
- 92
- Published applications
- 140
- Assignees
- 64
- Inventors
- 213
- Latest grant
- 11 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 1 | 0 |
| 1998 | 2 | 0 |
| 1999 | 2 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 4 | 4 |
| 2003 | 2 | 4 |
| 2004 | 0 | 4 |
| 2005 | 2 | 5 |
| 2006 | 0 | 4 |
| 2007 | 4 | 6 |
| 2008 | 2 | 6 |
| 2009 | 3 | 5 |
| 2010 | 1 | 5 |
| 2011 | 4 | 3 |
| 2012 | 5 | 11 |
| 2013 | 7 | 7 |
| 2014 | 5 | 5 |
| 2015 | 3 | 5 |
| 2016 | 7 | 12 |
| 2017 | 3 | 8 |
| 2018 | 3 | 5 |
| 2019 | 2 | 7 |
| 2020 | 6 | 8 |
| 2021 | 2 | 5 |
| 2022 | 4 | 6 |
| 2023 | 5 | 4 |
| 2024 | 5 | 5 |
| 2025 | 2 | 4 |
| 2026 | 5 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Epinephrine-based ophthalmic compositions for intraocular administration and methods for fabricating thereof11 Aug 2026US 12,702,651 B2Harrow IP, LLC
- Methods and compositions for treatment of mydriasis17 Mar 2026US 12,576,066 B2Opus Genetics, Inc.
- Methods and compositions for treatment of mydriasis17 Mar 2026US 12,576,067 B2Opus Genetics, Inc.
- Dissolvable medical device for drugs delivery20 Jan 2026US 12,527,688 B2Alcon Inc.
- Composition based on gellan gum and phenylephrine, production method and use as an ophthalmic product20 Jan 2026US 12,527,752 B2Unither Pharmaceuticals
- Methods and compositions for treatment of mydriasis10 Sep 2026US 2026/0263422 A1Opus Genetics, Inc.
- Atropine-containing aqueous composition2 Jul 2026US 2026/0183235 A1
- Methods and compositions for treatment of mydriasis22 May 2025US 2025/0161274 A1Opus Genetics, Inc.
- Methods and compositions for treatment of mydriasis22 May 2025US 2025/0161275 A1Opus Genetics, Inc.
- M-choline receptor agonist compound, preparation method therefor and use thereof15 May 2025US 2025/0154135 A1Nanjing Gritpharma Co., Ltd.
Most cited
By later US patents
- Controlled release of pharmaceuticals in the anterior chamber of the eye111US 5,972,326 A1999
- Peptide-lipid conjugates, liposomes and lipsomal drug delivery70US 6,339,069 B12002
- Ophthalmic compositions containing galactomannan polymers and borate69US 6,403,609 B1Alcon Manufacturing, Ltd. · 2002
- Ophthalmic compositions containing galactomannan polymers and borate53US 6,486,138 B1Alcon Manufacturing, Ltd. · 2002
- Ophthalmic compositions containing galactomannan polymers and borate36US 6,583,124 B2Alcon Manufacturing, Ltd. · 2003